Clin2
NCT07120048Possibly a fitRecruiting

Study of the INSPIRIS RESILIA Aortic Valve in real-world use

Aortic Valve Disease

Part of Heart & circulation clinical trials.

This study collects information on people who receive the INSPIRIS RESILIA aortic valve as part of their regular care. Researchers want to see how well the valve works in everyday practice.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
500 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are scheduled to have your aortic valve replaced with the INSPIRIS RESILIA valve.
  • You have had standard imaging tests (like an echocardiogram or CT scan) before the procedure.
  • You are 18 years or older.
  • You are willing and able to give written permission (informed consent) to be part of the study.
  • You do not have an active infection in your heart (endocarditis or myocarditis) or have had one in the last 3 months.
  • You are not having an emergency heart valve surgery, and you are not having another heart valve procedure at the same time.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07619872Recruiting
Safety study of KONECT RESILIA heart valve replacement

This study tracks how well a new artificial aortic valve and aorta graft (called KONECT RESILIA) work after surgery in real-world patients. Researchers want to understand if it's safe and performs well over time in people who need this valve replaced.

München, Bavaria
NCT07021612Recruiting
Registry study of TAVI for severe aortic regurgitation

This study is for people with a severe leaking aortic valve (aortic regurgitation) who are too high-risk for open-heart surgery. It tracks how well a less-invasive valve replacement (TAVI) using the JenaValve or J-Valve works for them.

Hong Kong, Shatin
NCT06688448Recruiting
New biologic aortic valve replacement study

This study is testing a new generation of biologic (tissue) replacement valves for the aortic valve in adults aged 18 to 65. It aims to see how well these newer devices work compared to standard options.

São Paulo, São Paulo
NCT06420830Recruiting
Study of a new heart valve in TAVR

This study follows patients with severe aortic stenosis who get a new heart valve (the SAPIEN 3 Ultra RESILIA) through a less invasive procedure (TAVR). Researchers want to see how well this valve works over time using special heart ultrasound tests.

Québec, Quebec
NCT05572710Recruiting
Aortic valve patients share real-world safety and outcomes

This observational registry collects information about people who need an aortic valve replacement using a biologic (bioprosthesis) valve. It aims to better understand safety and effectiveness in everyday care, not to test a new drug or procedure.

Leuven, Vlaams-Brabant
NCT07684313Not yet recruiting
Study of TRIFORMIS RESILIA valve in the real world (TRIBLAZE Study)

This study looks at how well the TRIFORMIS RESILIA valve works in people who need a new valve for a damaged native or artificial heart valve. It aims to check safety and how the valve performs over time.

Carmel, Indiana

Hear when a new Aortic Valve Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.